- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 61.64M sh |
| Shares Diluted | Q1 2026 · Mar 29, 2026 | 61.24M sh |
| Shares Diluted | Q1 2026 · Mar 30, 2025 | 60.77M sh |
| Capex | Q1 2026 · Mar 29, 2026 | $29.35M |
| Capex restated | Q1 2026 · Mar 30, 2025 | $36.54M |
| Operating Cash Flow | Q1 2026 · Mar 29, 2026 | $34.46M |
| Operating Cash Flow | Q1 2026 · Mar 30, 2025 | $20.14M |
| Cash And Equivalents | Q1 2026 · Mar 29, 2026 | $23.57M |
| Cash And Equivalents | Q1 2026 · Dec 28, 2025 | $21.25M |
| Stockholders Equity | Q1 2026 · Mar 29, 2026 | $627.66M |
| Stockholders Equity | Q1 2026 · Dec 28, 2025 | $626.28M |
| Stockholders Equity | Q1 2026 · Mar 30, 2025 | $596.29M |
| Stockholders Equity | Q1 2026 · Dec 29, 2024 | $595.39M |
| Current Liabilities | Q1 2026 · Mar 29, 2026 | $177.49M |
| Current Liabilities | Q1 2026 · Dec 28, 2025 | $167.5M |
| Total Liabilities | Q1 2026 · Mar 29, 2026 | $1.15B |
| Total Liabilities | Q1 2026 · Dec 28, 2025 | $1.12B |
| Current Assets | Q1 2026 · Mar 29, 2026 | $51.57M |
| Current Assets | Q1 2026 · Dec 28, 2025 | $49.08M |
| Total Assets | Q1 2026 · Mar 29, 2026 | $1.77B |
| Total Assets | Q1 2026 · Dec 28, 2025 | $1.74B |
| Eps Diluted | Q1 2026 · Mar 29, 2026 | −$0.04 |
| Eps Diluted | Q1 2026 · Mar 30, 2025 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 29, 2026 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 30, 2025 | −$0.01 |
| Sga Expense | Q1 2026 · Mar 29, 2026 | $39.95M |
| Sga Expense | Q1 2026 · Mar 30, 2025 | $30.22M |
| Net Income | Q1 2026 · Mar 29, 2026 | −$2.69M |
| Net Income | Q1 2026 · Mar 30, 2025 | −$829K |
| Operating Income | Q1 2026 · Mar 29, 2026 | $999K |
| Operating Income | Q1 2026 · Mar 30, 2025 | $1.11M |
| Revenue | Q1 2026 · Mar 29, 2026 | $330.96M |
| Revenue | Q1 2026 · Mar 30, 2025 | $282.24M |